Author details

Full Name

Astrid Gnekow

Affiliation

ORCID

Career Start Year

1987

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37875569	Author Correction: Multiomic neuropathology improves diagnostic accuracy in pediatric neuro-oncology.	Nat Med	2024
36928815	Multiomic neuropathology improves diagnostic accuracy in pediatric neuro-oncology.	Nat Med	2023
36905830	Comprehensive neurological evaluation of a cohort of patients with neurofibromatosis type 1 from a single institution.		2023
37260252	Neurosurgical morbidity in pediatric supratentorial midline low-grade glioma: Results from the German LGG studies.	Int J Cancer	2023
34933039	Pseudoprogression Is Frequent After Front-Line Radiation Therapy in Pediatric Low-Grade Glioma: Results From the German Low-Grade Glioma Cohort.	International Journal of Radiation Oncology Biology Physics	2022
35713653	Neurofibromatosis type 1: A comparison of the 1997 NIH and the 2021 revised diagnostic criteria in 75Â children and adolescents.	Genetics in Medicine	2022
35901673	Long-term follow-up of surgical intervention pattern in pediatric low-grade gliomas: report from the German SIOP-LGG 2004 cohort.	J Neurosurg Pediatr	2022
32619305	Biology and grading of pleomorphic xanthoastrocytoma-what have we learned about it?	Brain Pathol	2021
33971689	Doubling Recruitment of Pediatric Low-grade Glioma within Two Decades does not change Outcome - Report from the German LGG Studies.	Klin Padiatr	2021
33585982	Integrated molecular and clinical analysis of low-grade gliomas in children with neurofibromatosis type 1 (NF1).	Acta Neuropathol	2021
33714975	Hepatic sinusoidal obstruction syndrome and short-term application of 6-thioguanine in pediatric acute lymphoblastic leukemia.	Leukemia	2021
33346834	High frequency of disease progression in pediatric spinal cord low-grade glioma (LGG): management strategies and results from the German LGG study group.	Neuro-Oncology	2021
33336421	Accurate calling of KIAA1549-BRAF fusions from DNA of human brain tumours using methylation array-based copy number and gene panel sequencing data.	Neuropathol Appl Neurobiol	2021
32580249	Loss of efficacy of subsequent nonsurgical therapy after primary treatment failure in pediatric low-grade glioma patients-Report from the German SIOP-LGG 2004 cohort.	Int J Cancer	2020
32239677	Prognostic impact of distinct genetic entities in pediatric diffuse glioma WHO-grade II-Report from the German/Swiss SIOP-LGG 2004 cohort.	Int J Cancer	2020
31613986	Favorable prognosis in pediatric brainstem low-grade glioma: Report from the German SIOP-LGG 2004 cohort.	Int J Cancer	2020
33026636	Response to trametinib treatment in progressive pediatric low-grade glioma patients.	J Neurooncol	2020
32968720	Long-term cognitive deficits in pediatric low-grade glioma (LGG) survivors reflect pretreatment conditions-report from the German LGG studies.	Neurooncol Adv	2020
31108561	SIOP-E-BTG and GPOH Guidelines for Diagnosis and Treatment of Children and Adolescents with Low Grade Glioma.	Klin Padiatr	2019
32079032	Correction: SIOP-E-BTG and GPOH Guidelines for Diagnosis and Treatment of Children and Adolescents with Low Grade Glioma.	Klin Padiatr	2019
31772664	Natural History of Pediatric Low-Grade Glioma Disease - First Multi-State Model Analysis.	J Cancer	2019
30262570	THROMBOTECT - a randomized study comparing low molecular weight heparin, antithrombin and unfractionated heparin for thromboprophylaxis during induction therapy of acute lymphoblastic leukemia in children and adolescents.	Haematologica	2019
30793186	Health status, health-related quality of life, and socioeconomic outcome in childhood brain tumor survivors: a German cohort study.	Neuro Oncol	2019
29539639	DNA methylation-based classification of central nervous system tumours.	Nature	2018
29890518	Management of Primary Tectal Plate Low-Grade Glioma in Pediatric Patients: Results of the Multicenter Treatment Study SIOP-LGG 2004.	Neuropediatrics	2018
29248309	Corrigendum to "A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (â¿¤16Â years) low grade glioma - A final report" [Eur J of Canc (2	European Journal of Cancer	2018
28168833	Childhood cancer predisposition syndromes-A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology.	Am J Med Genet A	2017
29040054	Pediatric NUT-midline carcinoma: Therapeutic success employing a sarcoma based multimodal approach.	Pediatric Hematology and Oncology	2017
28649001	A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (â¿¤16Â years) low grade gliomaÂ - A final report.	European Journal of Cancer	2017
31385995	Management of primary thalamic low-grade glioma in pediatric patients: results of the multicenter treatment studies HIT-LGG 1996 and SIOP-LGG 2004.	Neurooncol Pract	2017
26084390	Molecular characterization of disseminated pilocytic astrocytomas.	Neuropathol Appl Neurobiol	2016
27147083	Intraventricular etoposide safety and toxicity profile in children and young adults with refractory or recurrent malignant brain tumors.	J Neurooncol	2016
26826417	Intramedullary gangliogliomas: histopathologic and molecular features of 25 cases.	Human Pathology	2016
26278499	Strategies to improve the quality of survival for childhood brain tumour survivors.	Eur J Paediatr Neurol	2015
25666233	Differential imaging characteristics and dissemination potential of pilomyxoid astrocytomas versus pilocytic astrocytomas.	Neuroradiology	2015
24039013	Children <1 year show an inferior outcome when treated according to the traditional LGG treatment strategy: a report from the German multicenter trial HIT-LGG 1996 for children with low grade glioma (LGG).	Pediatric Blood and Cancer	2014
23831852	Radiotherapy in pediatric pilocytic astrocytomas. A subgroup analysis within the prospective multicenter study HIT-LGG 1996 by the German Society of Pediatric Oncology and Hematology (GPOH).	Strahlentherapie und Onkologie	2013
23868007	Cerebellar location may predict an unfavourable prognosis in paediatric high-grade glioma.	British Journal of Cancer	2013
21987345	Infarction following chiasmatic low grade glioma resection.	Child's Nervous System	2012
22942186	Long-term follow-up of the multicenter, multidisciplinary treatment study HIT-LGG-1996 for low-grade glioma in children and adolescents of the German Speaking Society of Pediatric Oncology and Hematology.	Neuro-Oncology	2012
21636712	Thalamic high-grade gliomas in children: a distinct clinical subset?	Neuro-Oncology	2011
24059664	Contrast Enhancement of Low Grade Gliomas (LGG) during Follow-Up.	Neuroradiology Journal	2011
21424530	Oncogenic FAM131B-BRAF fusion resulting from 7q34 deletion comprises an alternative mechanism of MAPK pathway activation in pilocytic astrocytoma.	Acta Neuropathol	2011
21378352	Pediatric neuro-oncology in small centers--quality control of network support: the HIT-GBM experience.	Anticancer Res	2011
21319282	Impact of chemotherapy on disseminated low-grade glioma in children and adolescents: report from the HIT-LGG 1996 trial.	Pediatr Blood Cancer	2011
20658624	Measuring performance status in pediatric patients with brain tumors--experience of the HIT-GBM-C protocol.	Pediatr Blood Cancer	2010
20352473	Natural history and management of low-grade glioma in NF-1 children.	Journal of Neuro-Oncology	2010
20512571	Invasive aspergillosis osteomyelitis in children--a case report and review of the literature.	Skeletal Radiology	2010
19957326	Intensive chemotherapy improves survival in pediatric high-grade glioma after gross total resection: results of the HIT-GBM-C protocol.	Cancer	2010
18818397	Treatment of early childhood medulloblastoma by postoperative chemotherapy and deferred radiotherapy.	Neuro Oncol	2009